IP Library › Assignment 062452/0106
Patent Assignment
Reel/Frame 062452/0106

Security Interest

Recorded: 2023-01-23 Pages: 6
Assignors
HARROW HEALTH, INC.
Executed: 2023-01-20
HARROW IP, LLC
Executed: 2023-01-20
IMPRIMISRX, LLC
Executed: 2023-01-20
HARROW EYE, LLC
Executed: 2023-01-20
IMPRIMIS NJOF, LLC
Executed: 2023-01-20
IMPRIMISRX NJ, LLC
Executed: 2023-01-20
VISIONOLOGY EQUITY, LLC
Executed: 2023-01-20
VISIONOLOGY, INC.
Executed: 2023-01-20
VISIONOLOGY MSO, INC.
Executed: 2023-01-20
Assignee
B. RILEY COMMERCIAL CAPITAL, LLC, AS ADMINISTRATIVE AGENT
11100 SANTA MONICA BLVD., STE. 800, LOS ANGELES, CALIFORNIA, 90025
Covered Properties (8)
Topical Nepafenac Formulations
Patent: 7,834,059 →
Application: 11/292,484 →
Publication: US 2006/0122277
Ophthalmic Compositions Containing a Synergistic Combination of Two Polymers
Patent: 7,947,295 →
Application: 11/673,070 →
Publication: US 2007/0128156
Low Viscosity, Highly Flocculated Triamcinolone Acetonide Suspensions for Intravitreal Injection
Patent: 8,128,960 →
Application: 12/401,168 →
Publication: US 2009/0233890
Topical Nepafenac Formulations
Patent: 8,071,648 →
Application: 12/888,631 →
Publication: US 2011/0015271
Carboxyvinyl Polymer-Containing Nanoparticle Suspensions
Patent: 8,921,337 →
Application: 12/957,864 →
Publication: US 2011/0135743
Topical Nepafenac Formulations
Patent: 8,324,281 →
Application: 13/253,648 →
Publication: US 2012/0029084
Low Viscosity, Highly Flocculated Triamcinolone Acetonide Suspensions for Intravitreal Injection
Patent: 8,211,880 →
Application: 13/352,009 →
Publication: US 2012/0116216
Carboxylvinyl Polymer-Containing Nanoparticle Suspensions
Patent: 9,662,398 →
Application: 14/539,996 →
Publication: US 2015/0072011
Related Assignments (15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 3, 2016
From: NOVARTIS AG
To: ALCON RESEARCH LTD.
Reel/Frame 037886/0357 →
Merger Oct 16, 2019
From: ALCON RESEARCH, LTD.
To: ALCON RESEARCH, LLC
Reel/Frame 050735/0465 →
Confirmatory Deed of Assignment Effective April 8, 2019 Oct 17, 2019
From: ALCON RESEARCH, LLC
To: NOVARTIS AG
Reel/Frame 050746/0431 →
Corrective Assignment to Correct the Assignee Address. Previously Recorded at Reel: 050746 Frame: 0431. Assignor(S) Hereby Confirms the Assignment.. Oct 18, 2019
From: ALCON RESEARCH, LLC
To: NOVARTIS AG
Reel/Frame 050767/0001 →
Confirmatory Deed of Assignment Effective April 8, 2019 Dec 10, 2019
From: NOVARTIS AG
To: ALCON INC.
Reel/Frame 051454/0788 →
Merger Dec 11, 2019
From: ALCON RESEARCH, LTD.
To: ALCON RESEARCH, LLC
Reel/Frame 051257/0562 →
Confirmatory Deed of Assignment Effective April 8, 2019 Dec 14, 2019
From: ALCON RESEARCH, LLC
To: ALCON INC.
Reel/Frame 051293/0444 →
Merger Jul 21, 2020
From: ALCON RESEARCH, LTD.
To: ALCON RESEARCH, LLC
Reel/Frame 053273/0022 →
Confirmatory Deed of Assignment Effective April 8, 2019 Jul 23, 2020
From: ALCON RESEARCH, LLC
To: ALCON INC.
Reel/Frame 053293/0484 →
Assignment of Assignor's Interest Jan 15, 2021
From: ALCON INC.
To: NOVARTIS AG
Reel/Frame 054934/0300 →
Assignment of Assignor's Interest Jan 20, 2023
From: NOVARTIS AG
To: HARROW IP, LLC
Reel/Frame 062442/0255 →
Termination and Release of Security Interest in Intellectual Property at Reel/Frame No. 62452/0106 Mar 30, 2023
From: B. RILEY COMMERCIAL CAPITAL, LLC, AS ADMINISTRATIVE AGENT
To: HARROW HEALTH, INC.; HARROW EYE, LLC; HARROW IP, LLC; IMPRIMISRX, LLC
Reel/Frame 063206/0156 →
Patent Security Agreement Mar 30, 2023
From: HARROW IP, LLC
To: OAKTREE FUND ADMINISTRATION, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 063205/0708 →
Release of Security Interest Sep 18, 2025
From: OAKTREE FUND ADMINISTRATION, LLC, AS ADMINISTRATIVE AGENT
To: HARROW IP, LLC
Reel/Frame 072299/0911 →
Security Interest Sep 26, 2025
From: HARROW, INC.; HARROW IP, LLC
To: FIFTH THIRD BANK, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 072384/0781 →